Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBeximco Pharma Regulatory News (BXP)

  • This share is currently suspended. It was suspended at a price of 42.50

Share Price Information for Beximco Pharma (BXP)

Share Price is delayed by 15 minutes
Get Live Data
42.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £189.60m
BXP Live PriceLast checked at - London Stock Exchange

Intraday Beximco Pharma Share Chart

Notice of AGM - Amendment

6 May 2008 10:58

Beximco Pharmaceuticals Ltd06 May 2008 This announcement replaces RNS number 7576T and changes the Record Date to 2July 2008. BEXIMCO PHARMACEUTICALS LIMITED 17, DHANMONDI R.A, ROAD NO. 2, DHAKA-1205 NOTICE OF THE THIRTY-SECOND ANNUAL GENERAL MEETING Notice is hereby given that the THIRTY-SECOND ANNUAL GENERAL MEETING of theShareholders of Beximco Pharmaceuticals Limited will be held on Thursday, the21st August, 2008 at 10.30 a.m. at 1, Shahbag C/A, Dhaka to transact thefollowing business: AGENDA 1. To receive, consider and adopt the Audited Financial Statements of the Company for the year ended 31st December, 2007 together with reports of the Auditors and the Directors thereon. 2. To elect Directors. 3. To declare 5% Cash and 10% Stock Dividend. 4. To appoint Auditors for the year 2008 and to fix their remuneration. 5. To transact any other business of the Company with the permission of the Chair. By order of the Board, Sd/-Dated: 6th May, 2008 (MD. ASAD ULLAH, FCS) Company Secretary NOTES: (1) The Record Date shall be on 2nd July, 2008. The Shareholders whose nameswill appear in the Share Register of the Company or in the Depository Registeron that date will be entitled to attend at the Annual General Meeting and toreceive the dividend. (2) A member entitled to attend and vote at the General Meeting may appoint aProxy to attend and vote in his/her stead. The Proxy Form, duly stamped, must bedeposited at the Registered office of the Company not later than 48 hours beforethe time fixed for the meeting. (3) Admission to the meeting room will be strictly on production of theattendance slip sent with the Notice as well as verification of signature ofMember(s) and/or proxy-holder(s). This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
30th Jan 20237:00 amRNSHalf Year Results 2022-23
19th Jan 20237:00 amRNSPayment of Cash Dividend
23rd Dec 20227:00 amRNSAnnual General Meeting Statement
29th Nov 20222:06 pmRNSSecond Price Monitoring Extn
29th Nov 20222:00 pmRNSPrice Monitoring Extension
16th Nov 20227:00 amRNSAGM Notification
11th Nov 20227:00 amRNSFinancial Results for the First Quarter
8th Nov 20227:00 amRNSResults for the 12-month period ended 30 June 2022
28th Oct 20227:00 amRNSNotification of Preliminary Results and AGM
28th Apr 20227:00 amRNSQ3 Financial Results
1st Apr 20227:00 amRNSSanofi Bangladesh Ltd. renamed Synovia Pharma PLC
17th Mar 20222:30 pmRNSMPP sub-license for Pfizer’s COVID-19 treatment
28th Jan 20227:00 amRNSHalf Year Results 2021-22
21st Jan 20227:00 amRNSPayment of Cash Dividend
20th Jan 20229:00 amRNSLicense to produce molnupiravir for COVID-19
30th Dec 202110:38 amRNSWorld's first generic version of Pfizer’s Paxlovid
24th Dec 20217:00 amRNSAnnual General Meeting Statement
8th Dec 20217:00 amRNSDelivery of COVID-19 vaccine doses
2nd Dec 20217:00 amRNSUpdate on the supply of COVID-19 vaccine
24th Nov 20217:43 amRNSStatement re: media comment
16th Nov 20217:00 amRNSNotice of AGM
11th Nov 202110:30 amRNSResults for First Quarter Ended 30 September 2021
9th Nov 20217:00 amRNSLaunch of world’s first generic molnupiravir
2nd Nov 20217:00 amRNSResults for the year ended 30 June 2021
21st Oct 202112:36 pmRNSNotification of Preliminary Results and AGM
11th Oct 20217:00 amRNSUpdate on the supply of COVID-19 vaccine
1st Oct 20217:00 amRNSCompletion of Sanofi Bangladesh Acquisition
14th Sep 202110:20 amRNSSanofi Bangladesh Share Purchase Agreement signed
3rd Sep 20211:10 pmRNSAcquisition Approved by Bangladesh Bank
25th Aug 20216:01 pmRNSStatement re: media comment
26th Jul 20217:00 amRNSFDA approval for muscle relaxant drug Baclofen
7th Jul 20212:23 pmRNSUpdate on the supply of COVID-19 vaccine
30th Apr 20217:00 amRNSQ3 Financial Results
28th Apr 20217:00 amRNSUpdate on the supply of COVID-19 vaccine
24th Mar 20214:41 pmRNSSecond Price Monitoring Extn
24th Mar 20214:36 pmRNSPrice Monitoring Extension
24th Mar 20212:06 pmRNSSecond Price Monitoring Extn
24th Mar 20212:00 pmRNSPrice Monitoring Extension
24th Mar 202111:06 amRNSSecond Price Monitoring Extn
24th Mar 202111:00 amRNSPrice Monitoring Extension
4th Feb 20217:34 amRNSUpdate on the supply of COVID-19 vaccine
28th Jan 20217:00 amRNSHalf Year Results 2020-21
22nd Jan 20217:00 amRNSPayment of Cash Dividend
21st Jan 20219:34 amRNSProposed acquisition of stake in Sanofi Bangladesh
18th Jan 20217:00 amRNSBoard Changes
14th Jan 20219:00 amRNSUpdate on the supply of COVID-19 vaccine
11th Jan 20217:00 amRNSStock Dividend Issued
11th Jan 20217:00 amRNSConfirmation of Board Changes
21st Dec 20207:00 amRNSAGM Statement
2nd Dec 202011:01 amRNSBoard Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.